You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 3, March 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Occult Choroidal Neovascularization in Age-Related Macular Degeneration

A Natural History Study

Thomas S. Stevens, MD; Neil M. Bressler, MD; Maureen G. Maguire, PhD; Susan B. Bressler, MD; Stuart L. Fine, MD; Judith Alexander; Deborah A. Phillips; Raymond R. Margherio, MD; Patrick L. Murphy, MD; Andrew P. Schachat, MD

Arch Ophthalmol. 1997;115(3):345-350.


Abstract

Objective
To explore morphological and vision changes in untreated eyes with subfoveal choroidal neovascularization (CNV) that have poorly demarcated boundaries.

Design
Analysis of photographs of untreated patients with poorly demarcated occult CNV participating in a prospective clinical trial evaluating laser treatment compared with observation.

Setting
Two tertiary retinal referral centers.

Patients
Symptomatic individuals with poorly demarcated subfoveal occult CNV associated with age-related macular degeneration.

Main Outcome Measures
Change in size of lesion, development of classic CNV, change in vision, and development of subretinal fibrosis.

Results
During follow-up (9-12 months), 32% of the occult choroidal neovascular lesions more than doubled their original size. Classic CNV developed in 52% of eyes that started without it. The median loss in visual acuity was 2.5 lines. Eyes with classic CNV or subretinal blood or both at baseline developed subretinal fibrosis more frequently and lost more visual acuity, but not to a statistically significant degree.

Conclusions
The morphological changes of eyes with subfoveal occult CNV in which the boundaries are poorly demarcated is variable; the presence of subretinal blood or a component of classic CNV may influence the prognosis for further loss of vision.



Author Affiliations

From the Department of Ophthalmology, University of Wisconsin—Madison (Dr Stevens); Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine and Hospital, Baltimore, Md (Drs N. Bressler, S. Bressler, and Schachat and Mss Alexander and Phillips); The Scheie Eye Institute, University of Pennsylvania School of Medicine, Philadelphia (Drs Maguire and Fine); Associated Retinal Consultants, Royal Oak, Mich (Dr Margherio); and University Eye Associates, Wayne State University, St Clair Shores, Mich (Dr Murphy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Incident Choroidal Neovascularization in Fellow Eyes of Patients With Unilateral Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: SST Report No. 20 From the Submacular Surgery Trials Research Group
Submacular Surgery Trials Research Group
Arch Ophthalmol 2007;125:1323-1330.
ABSTRACT | FULL TEXT  

Dynamic and Quantitative Analysis of Choroidal Neovascularization by Fluorescein Angiography
Shah et al.
IOVS 2006;47:5460-5468.
ABSTRACT | FULL TEXT  

Lesion morphology in age-related macular degeneration and its therapeutic significance.
Beaumont and Kang
Arch Ophthalmol 2006;124:807-812.
ABSTRACT | FULL TEXT  

Large Spot Transpupillary Thermotherapy for Occult Choroidal Neovascularization
Spaide et al.
Arch Ophthalmol 2005;123:1272-1273.
FULL TEXT  

Morphometric Analysis of Angiograms of Exudative Lesions in Age-Related Macular Degeneration
Ali et al.
Arch Ophthalmol 2004;122:710-715.
ABSTRACT | FULL TEXT  

Clinicopathologic Correlation of Progressive Fibrovascular Proliferation Associated With Occult Choroidal Neovascularization in Age-Related Macular Degeneration
Csaky et al.
Arch Ophthalmol 2004;122:650-652.
FULL TEXT  

Case selection in macular relocation surgery for age related macular degeneration
Wong et al.
Br J Ophthalmol 2004;88:186-190.
ABSTRACT | FULL TEXT  

Large-Spot Size Transpupillary Thermotherapy for the Treatment of Occult Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Thach et al.
Arch Ophthalmol 2003;121:817-820.
ABSTRACT | FULL TEXT  

Monitoring Retinal Function during Transpupillary Thermotherapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration
Falsini et al.
IOVS 2003;44:2133-2140.
ABSTRACT | FULL TEXT  

Decreased Visual Acuity Associated With Cystoid Macular Edema in Neovascular Age-related Macular Degeneration
Ting et al.
Arch Ophthalmol 2002;120:731-737.
ABSTRACT | FULL TEXT  

Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration
Haddad et al.
Br J Ophthalmol 2002;86:663-669.
ABSTRACT | FULL TEXT  

Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study
Donati et al.
Br J Ophthalmol 1999;83:646-651.
ABSTRACT | FULL TEXT  

Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration
Obana et al.
Br J Ophthalmol 1999;83:429-437.
ABSTRACT | FULL TEXT  

Indocyanine green guided laser photocoagulation in patients with occult choroidal neovascularisation
Weinberger et al.
Br J Ophthalmol 1999;83:168-172.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.